The role of idecabtagene vicleucel in patients with heavily pretreated refractory multiple myeloma.

Therapeutic Advances in Hematology
Albert OriolJosep-Maria Ribera

Abstract

The development of several treatment options over the last 2 decades has led to a notable improvement in the survival of patients with multiple myeloma. Despite these advances, the disease remains incurable for most patients. Moreover, standard combinations of alkylating agents, immunomodulatory drugs, proteasome inhibitors, and monoclonal antibodies targeting CD38 and corticoids are exhausted relatively fast in a proportion of high-risk patients. Such high-risk patients account for over 20% of cases and currently represent a major unmet medical need. The challenge of drug resistance requires the development of highly active new agents with a radically different mechanism of action. Several immunotherapeutic modalities, including antibody-drug conjugates and T-cell engagers, appear to be promising choices for patients who develop resistance to standard combinations. Chimeric antigen-receptor-modified T cells (CAR-Ts) targeting B-cell maturation antigen have demonstrated encouraging efficacy and an acceptable safety profile compared with alternative options. Multiple CAR-Ts are in early stages of clinical development, but the first phase III trials with CAR-Ts are ongoing for two of them. After the recent publication of the resu...Continue Reading

References

Jan 7, 2004·The Journal of Experimental Medicine·Brian P O'ConnorRandolph J Noelle
Mar 7, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Micah J BensonRandolph J Noelle
Jul 14, 2012·Blood·Laura RosiñolUNKNOWN Programa para el Estudio y la Terapéutica de las Hemopatías Malignas/Grupo Español de Mieloma (PETHEMA/GEM) group
Jul 19, 2012·British Journal of Haematology·Eric SanchezJames R Berenson
Jan 25, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert O CarpenterJames N Kochenderfer
Apr 27, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael HudecekStanley R Riddell
Jan 15, 2014·Leukemia·S Y KristinssonO Landgren
Apr 4, 2015·Blood·Philippe MoreauThierry Facon
Jun 13, 2015·Nature Communications·Sarah A LaurentEdgar Meinl
Jul 2, 2015·Nature Reviews. Drug Discovery·Sjoukje J C van der StegenMichel Sadelain
Nov 13, 2015·British Journal of Haematology·Shannon Maude, David M Barrett
Apr 6, 2017·The New England Journal of Medicine·Michel AttalUNKNOWN IFM 2009 Study
Jul 26, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Philip L McCarthyMichel Attal
Dec 13, 2017·The New England Journal of Medicine·María-Victoria MateosUNKNOWN ALCYONE Trial Investigators
May 31, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jennifer N BrudnoJames N Kochenderfer
Nov 8, 2018·The New England Journal of Medicine·Meletios A DimopoulosJesús San-Miguel
Mar 22, 2019·Blood Cancer Journal·Philippe MoreauMaria-Victoria Mateos
Mar 22, 2019·The Journal of Clinical Investigation·Adam D CohenMichael C Milone
May 3, 2019·The New England Journal of Medicine·Noopur RajeJames N Kochenderfer
May 30, 2019·The New England Journal of Medicine·Thierry FaconUNKNOWN MAIA Trial Investigators
Aug 23, 2019·The New England Journal of Medicine·Ajai ChariSundar Jagannath
Jan 3, 2020·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Max S ToppHermann Einsele
Oct 7, 2020·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Meletios A DimopoulosUNKNOWN TOURMALINE-MM4 study group

❮ Previous
Next ❯

Software Mentioned

CAR

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
Keisuke KidoguchiTetsuya Tanimoto
The New England Journal of Medicine
Alfonso Quintás-Cardama
The New England Journal of Medicine
Nikhil C MunshiJesús San-Miguel
Clinical Lymphoma, Myeloma & Leukemia
Mikiko IseKyoya Kumagai
© 2021 Meta ULC. All rights reserved